198 related articles for article (PubMed ID: 30120925)
1. An observational study to test the acceptability and feasibility of using medical and nursing students to instruct clients in DMPA-SC self-injection at the community level in Kinshasa.
Bertrand JT; Bidashimwa D; Makani PB; Hernandez JH; Akilimali P; Binanga A
Contraception; 2018 Nov; 98(5):411-417. PubMed ID: 30120925
[TBL] [Abstract][Full Text] [Related]
2. Task-shifting the provision of DMPA-SC in the DR Congo: Perspectives from two different groups of providers.
Hernandez JH; Akilimali P; Glover A; Emel R; Mwembo A; Bertrand J
Contraception; 2018 Nov; 98(5):449-453. PubMed ID: 30031000
[TBL] [Abstract][Full Text] [Related]
3. Client and provider experiences with self-administration of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in Malawi.
Burke HM; Packer C; Buluzi M; Healy E; Ngwira B
Contraception; 2018 Nov; 98(5):405-410. PubMed ID: 29706227
[TBL] [Abstract][Full Text] [Related]
4. Effect of self-administration versus provider-administered injection of subcutaneous depot medroxyprogesterone acetate on continuation rates in Malawi: a randomised controlled trial.
Burke HM; Chen M; Buluzi M; Fuchs R; Wevill S; Venkatasubramanian L; Dal Santo L; Ngwira B
Lancet Glob Health; 2018 May; 6(5):e568-e578. PubMed ID: 29526707
[TBL] [Abstract][Full Text] [Related]
5. Continuation of self-injected versus provider-administered contraception in Senegal: a nonrandomized, prospective cohort study.
Cover J; Ba M; Drake JK; NDiaye MD
Contraception; 2019 Feb; 99(2):137-141. PubMed ID: 30439358
[TBL] [Abstract][Full Text] [Related]
6. Women's satisfaction, use, storage and disposal of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) during a randomized trial.
Burke HM; Chen M; Buluzi M; Fuchs R; Wevill S; Venkatasubramanian L; Dal Santo L; Ngwira B
Contraception; 2018 Nov; 98(5):418-422. PubMed ID: 29758176
[TBL] [Abstract][Full Text] [Related]
7. Acceptability of the community-level provision of Sayana® Press by medical and nursing students in Kinshasa, Democratic Republic of the Congo.
Bertrand JT; Makani PB; Hernandez J; Akilimali P; Mukengeshayi B; Babazadeh S; Binanga A
Contraception; 2017 Sep; 96(3):211-215. PubMed ID: 28647500
[TBL] [Abstract][Full Text] [Related]
8. Acceptability of the distribution of DMPA-SC by community health workers among acceptors in the rural province of Lualaba in the Democratic Republic of the Congo: a pilot study.
Mwembo A; Emel R; Koba T; Sankoko JB; Ngay A; Gay R; Bertrand JT
Contraception; 2018 Nov; 98(5):454-459. PubMed ID: 30118683
[TBL] [Abstract][Full Text] [Related]
9. Continuation of subcutaneous or intramuscular injectable contraception when administered by facility-based and community health workers: findings from a prospective cohort study in Burkina Faso and Uganda.
MacLachlan E; Atuyambe LM; Millogo T; Guiella G; Yaro S; Kasasa S; Bukenya J; Nyabigambo A; Mubiru F; Tumusiime J; Onadja Y; Zan LM; Goeum/Sanon C; Kouanda S; Namagembe A
Contraception; 2018 Nov; 98(5):423-429. PubMed ID: 30125558
[TBL] [Abstract][Full Text] [Related]
10. Continuation of injectable contraception when self-injected vs. administered by a facility-based health worker: a nonrandomized, prospective cohort study in Uganda.
Cover J; Namagembe A; Tumusiime J; Nsangi D; Lim J; Nakiganda-Busiku D
Contraception; 2018 Nov; 98(5):383-388. PubMed ID: 29654751
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the feasibility and acceptability of self-injection of subcutaneous depot medroxyprogesterone acetate (DMPA) in Senegal: a prospective cohort study.
Cover J; Ba M; Lim J; Drake JK; Daff BM
Contraception; 2017 Sep; 96(3):203-210. PubMed ID: 28673645
[TBL] [Abstract][Full Text] [Related]
12. Factors Affecting Continued Use of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC): A Secondary Analysis of a 1-Year Randomized Trial in Malawi.
Burke HM; Chen M; Buluzi M; Fuchs R; Wevill S; Venkatasubramanian L; Santo LD; Ngwira B
Glob Health Sci Pract; 2019 Mar; 7(1):54-65. PubMed ID: 30894394
[TBL] [Abstract][Full Text] [Related]
13. Interest in self-administration of subcutaneous depot medroxyprogesterone acetate in the United States.
Upadhyay UD; Zlidar VM; Foster DG
Contraception; 2016 Oct; 94(4):303-13. PubMed ID: 27326938
[TBL] [Abstract][Full Text] [Related]
14. Injectable contraception: emerging evidence on subcutaneous self-administration.
Lerma K; Goldthwaite LM
Curr Opin Obstet Gynecol; 2019 Dec; 31(6):464-470. PubMed ID: 31567445
[TBL] [Abstract][Full Text] [Related]
15. The role of training in effective simulated self-injection of subcutaneous depot medroxyprogesterone acetate: observations from a usability study.
Kaplan I; Ross D; Hilton F; Morgenstern D; Wolter K
Contraception; 2016 Oct; 94(4):314-20. PubMed ID: 27241898
[TBL] [Abstract][Full Text] [Related]
16. Costs of administering injectable contraceptives through health workers and self-injection: evidence from Burkina Faso, Uganda, and Senegal.
Di Giorgio L; Mvundura M; Tumusiime J; Namagembe A; Ba A; Belemsaga-Yugbare D; Morozoff C; Brouwer E; Ndour M; Drake JK
Contraception; 2018 Nov; 98(5):389-395. PubMed ID: 29859148
[TBL] [Abstract][Full Text] [Related]
17. Pilot study of home self-administration of subcutaneous depo-medroxyprogesterone acetate for contraception.
Cameron ST; Glasier A; Johnstone A
Contraception; 2012 May; 85(5):458-64. PubMed ID: 22079602
[TBL] [Abstract][Full Text] [Related]
18. Increased 1-year continuation of DMPA among women randomized to self-administration: results from a randomized controlled trial at Planned Parenthood.
Kohn JE; Simons HR; Della Badia L; Draper E; Morfesis J; Talmont E; Beasley A; McDonald M; Westhoff CL
Contraception; 2018 Mar; 97(3):198-204. PubMed ID: 29246818
[TBL] [Abstract][Full Text] [Related]
19. Feasibility and acceptability of using medical and nursing students to provide Implanon NXT at the community level in Kinshasa, Democratic Republic of Congo.
Hernandez JH; Akilimali P; Glover A; Bertrand JT
BMC Womens Health; 2020 Jun; 20(1):133. PubMed ID: 32580766
[TBL] [Abstract][Full Text] [Related]
20. Randomized clinical trial of self versus clinical administration of subcutaneous depot medroxyprogesterone acetate.
Beasley A; White KO; Cremers S; Westhoff C
Contraception; 2014 May; 89(5):352-6. PubMed ID: 24656555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
